共 226 条
[1]
Capelli S(2015)Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets Bone 79 12-1017
[2]
Donghi V(2015)Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets J Pediatr Endocrinol Metab JPEM 28 1009-180
[3]
Maruca K(2008)Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation Rev Endocr Metab Disord 9 171-1388
[4]
Vezzoli G(2011)A clinician's guide to X-linked hypophosphatemia J Bone Min Res Off J Am Soc Bone Min Res 26 1381-R30
[5]
Corbetta S(2014)Therapeutic management of hypophosphatemic rickets from infancy to adulthood Endocr Connect 3 R13-161
[6]
Brandi ML(2015)A practical clinical approach to paediatric phosphate disorders Endocr Dev 28 134-136
[7]
Mora S(2016)Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications Eur J Endocrinol 174 125-1998
[8]
Weber G(2018)Biology of fibroblast growth factor 23: from physiology to pathology Cold Spring Harb Perspect Med 8 a031260-2427
[9]
Razali NN(2018)Burosumab therapy in children with X-linked hypophosphatemia N Engl J Med 378 1987-247
[10]
Hwu TT(2019)Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial Lancet (London, England) 393 2416-603